Cognitive Decline and Dementia

What is cognitive decline?

Cognitive decline is a measurable drop in memory, attention, language, or executive function from a person's own baseline. It runs on a spectrum: subjective complaints first, then mild cognitive impairment, then dementia once daily activities are affected. The cause is rarely a single plaque. Fuel delivery to neurons, blood sugar, oxygen, infection, toxic load, and brain inflammation all feed it. A functional medicine approach localizes the deficit to a brain region, names the type of dementia, and treats the drivers in order of priority.

What causes cognitive decline when the standard workup looks normal?

The neurology referral finds nothing and the MRI reads as normal, yet the patient keeps losing function. The workup is not wrong so much as incomplete, because routine labs screen for disease that has already arrived, not for a brain slowly running out of fuel. Functional medicine asks the earlier question, which region is failing and what is starving or inflaming it, and that question has answers a clinician can act on now.

Why has the single-plaque model failed clinicians?

For decades the field chased amyloid as the cause of Alzheimer's, and through 2019 the drug trials built on that one hypothesis did not deliver. Alzheimer's is still only about two-thirds of dementia; vascular, Lewy body, and frontotemporal disease make up much of the rest, and many patients carry more than one at once.

Amyloid plaques recruit microglia and set off inflammation, but so do unstable blood sugar, low oxygen, chronic infection, and toxic exposure. The plaque is one node in a network, which is why treating it alone has done so little. There is a further twist: amyloid appears to be part of the brain's own immune defense, laid down to trap microbes that reach the tissue. Clear the plaque without addressing why the brain was defending itself, and you have removed a symptom while leaving the driver in place.

How does functional medicine localize the problem in the brain?

Symptoms map to regions. Trouble with attention and staying on topic is a frontal lobe pattern, and the clearest clue is a history that takes forever because the patient cannot stay on track. Trouble holding something just learned, while old memories stay intact, points to the hippocampus, the first area Alzheimer's attacks. Loss of long-term events reaches deeper into the medial temporal lobe. Visual hallucinations mean Lewy body disease, and a personality that changes, with disinhibition, means frontotemporal dementia.

The course teaches a brain regional localization form so a practitioner can place the deficit before ordering a single test. A patient who interrupts to tell you something before they forget it is showing an encoding problem. A spouse who constantly steers them back on topic is showing a frontal lobe problem.

What is the physiological web behind cognitive decline?

Neurons need fuel, oxygen, and a way to clear debris. Anemia lowers oxygen delivery and independently raises dementia risk. Low or swinging blood sugar starves the mitochondria that make ATP, and insulin resistance both deprives neurons of clean fuel and switches on tau pathways. Blood pressure, lung function, and circulation all decide how much oxygen reaches the brain, and they are often the highest-leverage place to start.

The brain also has to rebuild itself. In Alzheimer's, mitochondrial biogenesis is impaired, so neurons do not make enough mitochondria to hold their charge. Plasticity depends on fuel, oxygen, BDNF, and activation all being present at once. Blood-brain barrier breakdown is associated with dementia, and the brain's immune cells talk to the gut and the lungs, which is why a cognitive case so often leads back to digestion, the airway, or an old infection.

How do infections and toxins drive neuroinflammation?

Aging alone shifts microglia into a reactive, inflammatory state. Against that background, an infection can tip a patient fast. Herpes simplex, cytomegalovirus, Epstein-Barr, and other pathogens have been linked to Alzheimer's, and some travel directly into brain tissue. What matters is the cumulative load over a lifetime, as latent viruses reactivate, chronic infections smolder, and each flare recruits microglia and lays down more amyloid.

Chemicals, heavy metals, solvents, and mold feed the same fire. The course covers the infectious and toxic models in full, with one caution repeated throughout. This is usually not where you start. You stabilize fuel and inflammation first, then reduce burden once the patient is resilient enough to handle it.

Which dementia is it, and how do you read the differential?

The differential drives everything downstream. A rapid or stepwise decline suggests vascular disease. Slowness, rigidity, and hallucinations suggest Lewy body. Behavior change with upper motor neuron signs suggests frontotemporal disease. A head-injury history with scattered deficits suggests chronic traumatic encephalopathy. Before any of these, a clinician must rule out metabolic causes: kidney, heart, and lung disease that change brain metabolites.

Severity has to be staged alongside type. Subjective cognitive impairment is a complaint without a measurable deficit. Mild cognitive impairment means two cognitive domains are affected. Dementia is diagnosed once daily activities break down, then placed on a scale from one to seven. Some patterns hide in plain sight, as when gluten antibodies cross-react with the cerebellum and produce ataxia that looks like primary coordination loss.

Where do you start with a complex cognitive patient?

Management is about priority, not volume. Load a fragile brain with ten interventions at once and the patient gets worse. The course teaches an ordered method: optimize fuel to the mitochondria first, stay inside the brain's metabolic limits, raise BDNF, drive neurogenesis and plasticity, activate the failing pathways, and only then use fasting for autophagy.

Dosing has its own cautions. As dementia advances, cholinergic pathways degrade, and the same nerves run swallowing and gut motility, so piling on supplements can leave a late-stage patient nauseated. The course separates a generalized approach, useful for prevention, from a personalized one built on a specific patient's web.

For related reading, see Clinical Indicators a Patient is Too Systemically Fragile for Detox, Beyond Alzheimer's: Hidden Causes of Cognitive Decline, Neuroinflammation and Blood-Brain Barrier in Dementia, and Preventive Cardiology: How to Keep Heart Attacks at Bay.